Drug discovery today. Disease mechanisms最新文献_第7页

Endocannabinoids and obesity development – the adipose tissue 内源性大麻素和肥胖的发展-脂肪组织

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2010.12.002

Enzo Nisoli

{"title":"Endocannabinoids and obesity development – the adipose tissue","authors":"Enzo Nisoli","doi":"10.1016/j.ddmec.2010.12.002","DOIUrl":"10.1016/j.ddmec.2010.12.002","url":null,"abstract":"<div><p><span>The adipose tissue is an endocrine organ with a key role in energy metabolism. The expansion of body fat (particularly of visceral fat) contributes to the increased cardiovascular risk of obese individuals. Obesity and its metabolic complications are characterized by fat inflammation and by an overactive endocannabinoid (EC) system. Chronic treatment with cannabinoid receptor<span><span> type 1 (CB1R) antagonists leads to weight loss and improved cardiometabolic risk profile in obese rodents and humans. EC overactivity is a cause of mitochondrial dysfunction, which may trigger </span>endoplasmic reticulum stress in adipocytes and metabolically active organs, thus significantly contributing to the pathogenesis and progression of obesity. Among the major pathways involved in these processes, the nitric oxide-generating system and the </span></span>p38 MAPK pathways might be targets for the development of anti-obesity drugs. Peripheral CB1Rs, and possibly CB2Rs, also play significant roles in obesity and diabetes. Together, these findings support the concept that dietary/lifestyle interventions and pharmacologic compounds, able to attenuate EC overactivity in adipose and other metabolically active tissues, may be useful for the treatment of human obesity and related disorders.</p></div>","PeriodicalId":72843,"journal":{"name":"Drug discovery today. Disease mechanisms","volume":"7 3","pages":"Pages e199-e204"},"PeriodicalIF":0.0,"publicationDate":"2010-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ddmec.2010.12.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73263680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Oleoylethanolamide: a new player in energy metabolism control. Role in food intake 油基乙醇酰胺:能量代谢控制的新角色。在食物摄入中的作用

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2011.01.004

Pasqua Dipasquale , Adele Romano , Silvia Cianci, Laura Righetti, Silvana Gaetani

引用次数: 16

Contents page. 内容页面。

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/S1740-6765(11)00007-1

引用次数: 0

Endocannabinoids in the pathophysiology of obesity – The liver 内源性大麻素在肥胖病理生理中的作用-肝脏

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2010.11.001

Ariane Mallat , Sophie Lotersztajn

引用次数: 1

The role of phospholipase A2-derived mediators in obesity 磷脂酶a2衍生介质在肥胖中的作用

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2011.01.003

Marcia J. Abbott, Tianyi Tang, Hei Sook Sul

引用次数: 18

Endocannabinoids in the aetiopathology of obesity – Central mechanisms 内源性大麻素在肥胖病因病理学中的作用——中心机制

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2010.12.003

Tim C. Kirkham, Elizabeth K. Rogers

引用次数: 3

Palmitoylethanolamide, adipocytes and obesity-related inflammatory states 棕榈酰乙醇酰胺，脂肪细胞和肥胖相关炎症状态

Drug discovery today. Disease mechanisms Pub Date : 2010-12-01 DOI: 10.1016/j.ddmec.2011.01.002

Laurence Hoareau, Régis Roche

引用次数: 5

Highly specific modulators of protein kinase C localization: applications to heart failure 蛋白激酶C定位的高度特异性调节剂:在心力衰竭中的应用

Drug discovery today. Disease mechanisms Pub Date : 2010-06-01 DOI: 10.1016/j.ddmec.2010.07.001

Nir Qvit, Daria Mochly-Rosen

引用次数: 28

Ca2+/calmodulin-dependent protein kinase II in heart failure Ca2+/钙调素依赖性蛋白激酶II在心力衰竭中的作用

Drug discovery today. Disease mechanisms Pub Date : 2010-06-01 DOI: 10.1016/j.ddmec.2010.07.005

Howard Schulman , Mark E. Anderson

引用次数: 26

Refilling intracellular calcium stores 补充细胞内钙储存

Drug discovery today. Disease mechanisms Pub Date : 2010-06-01 DOI: 10.1016/j.ddmec.2010.08.004

Changwon Kho, Ahyoung Lee, Dongtak Jeong, Roger J. Hajjar

引用次数: 5